Filtered By:
Specialty: Cardiology
Condition: Headache

This page shows you your search results in order of date. This is page number 5.

Order by Relevance | Date

Total 101 results found since Jan 2013.

Abstract 121: Anxiety and Depression in Patients With Fibromuscular Dysplasia: A Report From the US Registry for Fibromuscular Dysplasia Session Title: Poster Session AM
Conclusions: More than 1/3 of patients in the FMD registry had A, D, or both, and these patients showed multiple differences compared to patients without A/D. More study is required to understand this relationship. Given the high prevalence of A/D in this population, FMD patients should be screened for the presence of A/D and offered appropriate treatment.
Source: Circulation: Cardiovascular Quality and Outcomes - April 5, 2018 Category: Cardiology Authors: Pawlik, C., Kline-Rogers, E., Olin, J. W., Gornik, H. L., Mace, P., Gu, X., Swan, K., Krallman, R., Kim, E. S., Wells, B. J., Weinberg, I., Sharma, A. M., Gray, B., Froehlich, J. B. Tags: Session Title: Poster Session AM Source Type: research

Clinical Use of the Amplatzer Device in the Management of Intracardiac Defects: A Single-Center Experience
Int J Angiol DOI: 10.1055/s-0038-1626718Device therapy is a viable alternative to open heart surgery in the management of intracardiac defects. The Amplatzer septal occluder (ASO) is one such device that has been adapted to close a wide variety of cardiac defects with few complications and a high success rate. This is a retrospective review of all the patients who received the ASO between 2012 and 2016 at the University of Kentucky. In total, 169 patients underwent percutaneous closure of a septal defect with Amplatzer during the timeframe studied, and of those, 91% received the device for an atrial septal defect or patent...
Source: International Journal of Angiology - January 30, 2018 Category: Cardiology Authors: Rao, Seema S. Scaff, Tyler L. Gurley, John Saha, Sibu Tags: Original Article Source Type: research

Simplified percutaneous closure of patent foramen ovale and atrial septal defect with use of plain fluoroscopy: Single operator experience in 110 consecutive patients.
CONCLUSION: Percutaneous placement of an Amplatzer occluder was safe and effective with use of local anesthesia and fluoroscopy alone. There were no recurrent strokes over >4 years. Migraine relief was reported by >80% of patients. PMID: 29455783 [PubMed - in process]
Source: Indian Heart J - January 1, 2018 Category: Cardiology Authors: Manolis AS, Koulouris S, Rouska E, Pyrros J Tags: Indian Heart J Source Type: research

Abstract 142: Angiotensin II Type 1 Receptor Autoantibody Inhibition Improves Blood Pressure and Markers of Neurological Damage and Oxidative Stress in Brains of Placental Ischemic Rats During Pregnancy Session Title: Developmental Programming and Pregnancy Induced Hypertension
In conclusion, our preliminary data suggests that AT1-AA inhibition could be a potential therapy to improve peripheral and neurological complications during PE. Research Supported by T32HL105324 (Cunningham), RO1HD067541-06 (LaMarca), DK-104184 (Roman), 050049 (Fan), P20-GM-104357 (cores B and C-Roman; Pilot-Fan) and AHA 16GRNT31200036 (Fan).
Source: Hypertension - September 14, 2017 Category: Cardiology Authors: Mark W Cunningham, Venkata Ramana Vaka, Lorena Amaral, Fan Fan, Tarek Ibrahim, Richard R Roman, Babbette LaMarca Tags: Oral Abstract Presentations Source Type: research

Acute ischemic stroke what is hidden behind?
We present a case of a 58-year-old male patient that presented to ED with sudden onset of headache and left-sided hemiparesis, computed tomography (CT) demonstrated an ischemic stroke of the right middle cerebral artery. When the question of whether to start r-TPA or mechanical thrombectomy was discussed, a cardiac point-of-care ultrasound was performed in ED and showed a type A aortic dissection; immediately a CT aortic angiogram was performed and confirmed the diagnosis. The patient was taken to theater and had a favorable outcome. <Learning objective: Acute aortic dissection (AAD) may present as acute ischemic st...
Source: Journal of Cardiology Cases - August 31, 2017 Category: Cardiology Source Type: research

Simplified Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defect With Use of Plain Fluoroscopy: Single Operator Experience in 110 Consecutive Patients
Conclusion Percutaneous placement of an Amplatzer occluder was safe and effective with use of local anesthesia and fluoroscopy alone. There were no recurrent strokes over >4years. Migraine relief was reported by >80% of patients.
Source: Indian Heart Journal - August 8, 2017 Category: Cardiology Source Type: research

Identification and Quantification of Patent Foramen Ovale –Mediated Shunts
Publication date: Available online 27 June 2017 Source:Interventional Cardiology Clinics Author(s): Ahmed N. Mahmoud, Islam Y. Elgendy, Nayan Agarwal, Jonathan M. Tobis, Mohammad Khalid MojadidiTeaser Once deemed benign, patent foramen ovale (PFO)–mediated right-to-left shunting has now been linked to stroke, migraine, and hypoxemia. Contrast transesophageal echocardiography is considered the standard technique for identifying a PFO, allowing visualization of the atrial septal anatomy and differentiation from non-PFO right-to-left shunts. Transthoracic echocardiography is the most common method for PFO imaging, being co...
Source: Interventional Cardiology Clinics - June 27, 2017 Category: Cardiology Source Type: research

A Phase 2a dose ‐escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS‐986231 in hospitalized patients with heart failure with reduced ejection fraction
ConclusionsBMS‐986231 demonstrated a favourable safety and haemodynamic profile in patients hospitalized with advanced heart failure. Based on preclinical data and these study's findings, it is possible that the haemodynamic benefits may be mediated by inotropic and/or lusitropic as well as vasodilatory effects. The therapeutic potential of BMS‐986231 should be further assessed in patients with heart failure.
Source: European Journal of Heart Failure - June 1, 2017 Category: Cardiology Authors: Cristina Tita, Edward M. Gilbert, Adrian B. Van Bakel, Jacek Grzybowski, Garrie J. Haas, Mohammad Jarrah, Stephanie H. Dunlap, Stephen S. Gottlieb, Marc Klapholz, Parag C. Patel, Roman Pfister, Tim Seidler, Keyur B. Shah, Tomasz Zieli ński, Robert P. Ven Tags: Original Article Source Type: research

Impaired endothelial function in patients with cryptogenic stroke and patent foramen ovale is not affected by closure
DiscussionEndothelial function did not change after closure of PFO. Although patients were lacking cardiovascular risk factors, a high proportion had impaired endothelial function. Whether ED can have predictive value, identifying PFO at higher risk for recurrent stroke warrants further investigations.
Source: Journal of Interventional Cardiology - April 25, 2017 Category: Cardiology Authors: Maria Lantz, Konstantinos Kostulas, Magnus Settergren, Christina Sj östrand Tags: ORIGINAL INVESTIGATION Source Type: research

Headache Common Stroke Symptom in Kids
(MedPage Today) -- While pediatric stroke is rare, nearly half present with pain
Source: MedPage Today Cardiovascular - February 23, 2017 Category: Cardiology Source Type: news

To close or not to close: contemporary indications for patent foramen ovale closure.
Authors: Zier LS, Sievert H, Mahadevan VS Abstract INTRODUCTION: Patent foramen ovale (PFO) is a common congenital cardiac abnormality and that has been associated with several disease processes including transient ischemic attacks (TIA), stroke, migraine headaches with aura, decompression sickness, platypnea-orthodeoxia syndrome, and shunt induced cyanosis. Controversy exists regarding closure of PFO as a therapeutic treatment modality for these disease processes. This review addresses the contemporary clinical indications for PFO closure. AREAS COVERED: We conducted a comprehensive literature search of contem...
Source: Expert Review of Cardiovascular Therapy - September 14, 2016 Category: Cardiology Tags: Expert Rev Cardiovasc Ther Source Type: research

Risk factors: Migraine — headache and heartache
Nature Reviews Cardiology 13, 442 (2016). doi:10.1038/nrcardio.2016.99 Author: Irene Fernández-Ruiz Women with migraine have a higher risk of cardiovascular disease and cardiovascular mortality, according to findings from a large, prospective cohort study with >20 years of follow-up. “In our study, migraine is associated with any cardiovascular outcome, that is, stroke, myocardial infarction, cardiovascular death, and
Source: Nature Reviews Cardiology - June 15, 2016 Category: Cardiology Authors: Irene Fernández-Ruiz Tags: Research Highlight Source Type: research

Mitochondrial vasculopathy.
Abstract Mitochondrial disorders (MIDs) are usually multisystem disorders (mitochondrial multiorgan disorder syndrome) either on from onset or starting at a point during the disease course. Most frequently affected tissues are those with a high oxygen demand such as the central nervous system, the muscle, endocrine glands, or the myocardium. Recently, it has been shown that rarely also the arteries may be affected (mitochondrial arteriopathy). This review focuses on the type, diagnosis, and treatment of mitochondrial vasculopathy in MID patients. A literature search using appropriate search terms was carried out. ...
Source: World Journal of Cardiology - May 25, 2016 Category: Cardiology Authors: Finsterer J, Zarrouk-Mahjoub S Tags: World J Cardiol Source Type: research

Cohort of renal infarction during 2years at Grenoble teaching hospital.
CONCLUSION: Delay of diagnosis is a real problem for renal infarction, and need to be evocated every flank pain. LDH elevation may help clinician to suggest renal infarction and lead to CT scan. Association of delayed inflammatory syndrome, hypertension and hypokalemia after flank pain strongly suggest renal infarction. PMID: 27180563 [PubMed - as supplied by publisher]
Source: Annales de Cardiologie et d'Angeiologie - May 11, 2016 Category: Cardiology Authors: Cerba Y, Franko B, Zaoui P Tags: Ann Cardiol Angeiol (Paris) Source Type: research

The Diagnosis and Treatment of Fibromuscular Dysplasia: An Update for Cardiologists
Opinion statement Fibromuscular dysplasia (FMD) is an arteriopathy of unknown etiology which has traditionally been associated with secondary hypertension; however, it has garnered increased attention in the cardiology field in the recent years because of its potential association with spontaneous coronary artery dissection. Cardiologists should be aware that FMD is a polyvascular disease which can affect any arterial bed and can result in morbid conditions such as chronic headaches, pulsatile tinnitus, stroke from cervical artery dissection, and renal infarction from renal artery dissection and has also been ass...
Source: Current Treatment Options in Cardiovascular Medicine - March 30, 2016 Category: Cardiology Source Type: research